Skip to main content

Table 3 Outcome, indication, use and assessment of aminoglycosides in the group of patients with S. aureus endocarditis

From: Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission

  Survivors (n = 20) Non survivors (n = 5) p
Indication of aminoglycosides 19/20 4/5 = 0.26
Delivery of aminoglycosides 15/20 2/5 = 0.12
Use of aminoglycosides in
Patients with indication
14/19 (73.6%) 1/4 (25%) = 0.07
Aminoglycosides conformity 14/20 (70%) 1/5 (20%) <  0.05